MARCH 6: Dr. Marty Makary, nominee to be commissioner of the U.S. Food and Drug Administration … More
Last evening, Dr. Marty Makary, President Trump’s pick to lead the U.S. Food and Drug Administration (FDA) was confirmed by the Senate by a vote of 56 to 44. One of the…
News Source: www.forbes.com
People think that sudden cardiac arrest as something that happens only to older, sick people. Yet in … More
Every so often, a young, seemingly healthy person has a sudden cardiac arrest—leaving friends, family, and the public stunned. A few examples:
News Source: www.forbes.com
Researchers from the University of Colorado Cancer Center have solved a cellular mystery that may lead to better therapies for colorectal and other types of cancer.
Peter Dempsey, PhD, professor of pediatrics-developmental biology in the CU School of Medicine, and Justin Brumbaugh, PhD, assistant professor of molecular, cellular, and developmental biology at CU Boulder, recently published a paper in the journal Nature Cell Biology showing the importance of the H3K36 methylation process in…
News Source: www.sciencedaily.com
In 2010, University of Oklahoma researcher David Fields, Ph.D., was pouring over research data when he discovered something he thought was odd: His data showed that at 6 months of age, formula-fed babies born of mothers who were categorized as medically obese weighed about 5% units less fat than breastfed babies in the same dataset. That discovery struck him as unusual and led him on a research journey to better understand breast milk. Now, he’s studying the connections between maternal…
News Source: www.sciencedaily.com
The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other antibodies are used by physicians to diagnose conditions or by scientists to advance research projects.
Even with significant expansion in the global market for antibodies used in clinical care and research, scientists recognize that there is still untapped potential for finding new antibodies. Many proteins group together in what are called protein complexes to carry out…
News Source: www.sciencedaily.com
Woman pouring sugar in bowl near breakfast
In today’s fast-paced world, ultra-processed foods have become dietary staples, offering convenience, affordability and a tantalizing taste. But as scientists delve deeper into their effects, an unsettling reality is emerging: UPFs may not just be unhealthy — they could be biologically addictive, contributing to a rise in obesity, metabolic disorders, and even cognitive decline.
Recent research, including a New York Times report…
News Source: www.forbes.com
Exposure to antibiotics during a key developmental window in infancy can stunt the growth of insulin-producing cells in the pancreas and may boost risk of diabetes later in life, new research in mice suggests.
The study, published this month in the journal Science, also pinpoints specific microorganisms that may help those critical cells proliferate in early life.
The findings are the latest to shine a light on the importance of the human infant microbiome — the constellation of bacteria…
News Source: www.sciencedaily.com
For human health, prematurely aging cells are a big problem. When a cell ages and stops growing, its function changes, which can cause or worsen cardiovascular disease, Alzheimer’s disease and other chronic diseases. But these cells are also like needles in a haystack, difficult to identify by traditional scientific measures.
To find these problematic cells, a University of Illinois Chicago doctoral student has developed a powerful new software platform called SenePy. In a paper for Nature…
News Source: www.sciencedaily.com
Zika virus and dengue virus are very close relatives. Both are mosquito-borne flaviviruses, and both specialize in infecting a host’s dendritic cells.
But a new Nature Communications study, led by scientists at La Jolla Institute for Immunology (LJI) and UC San Diego shows that these two viruses have vastly different ways of making us sick.
Zika virus uses stealth. Zika virus slips into dendritic cells and blocks the dendritic cells from alerting nearby T cells to danger. It’s the classic…
News Source: www.sciencedaily.com
A drug typically prescribed for arthritis halts brain-damaging seizures in mice that have a condition like epilepsy, according to researchers at the University of Wisconsin-Madison.
The drug, called tofacitinib, also restores short-term and working memory lost to epilepsy in the mice and reduces inflammation in the brain caused by the disease. If the drug proves viable for human patients, it would be the first to provide lasting relief from seizures even after they stopped taking it.
“It…
News Source: www.sciencedaily.com